Product information

Current status:

Cancelled Post Market

Current status date:

1996-09-09

Original market date: ^{See footnote 1}

1993-12-31

Product name:

ADENOCARD LIQ IV 3MG/ML

DIN:

02030306 Electronic product monograph is not available

Company:

FUJISAWA PHARMACEUTICAL CO, DIVISION OF FUJISAWA CANADA INC.
800 625 Cochrane Drive
Markham
Ontario
Canada L3R 9R9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

C01EB10 ADENOSINE

Active ingredient group (AIG) number:^{See footnote5}

0113219001